Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interventions for Severe Gag Reflex
NCT07099131Phase 1Not yet recruiting
- Sponsor
- Tufts University
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of lidocaine 10% oropharyngeal spray (3 arms), sponsored by Tufts University. Primary endpoint: Gagging Severity Index at 90 minutes. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
lidocaine 10% oropharyngeal spray
Beyond the preview
Go deeper on NCT07099131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07099131.